IQVIA Holdings (IQV) shares surged 7.57% in pre-market trading on Tuesday following the release of its impressive second-quarter 2025 financial results and optimistic full-year guidance. The healthcare data and analytics company demonstrated robust performance across key metrics, surpassing analyst expectations.
IQVIA reported adjusted earnings per share (EPS) of $2.81 for Q2, comfortably beating the consensus estimate of $2.77. The company's revenue also exceeded expectations, coming in at $4.02 billion compared to the projected $3.96 billion. This strong top-line performance was complemented by a healthy bottom line, with net income reaching $266 million for the quarter.
Adding to the positive sentiment, IQVIA provided an upbeat outlook for the full year 2025. The company now anticipates full-year revenue in the range of $16.1 billion to $16.3 billion, and adjusted EPS between $11.75 and $12.05. Furthermore, IQVIA projected full-year adjusted EBITDA to be between $3.75 billion and $3.825 billion, highlighting the company's confidence in its operational efficiency and profitability.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.